4.7 Review

Endocytosis of HIV: anything goes

期刊

TRENDS IN MICROBIOLOGY
卷 18, 期 12, 页码 543-551

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.tim.2010.09.003

关键词

-

资金

  1. Spanish Ministerio de Ciencia e Innovacion [BFI2003 00405, BFU2006 00966, FIS PI060624, BFU2009 06958, FIPSE 360783 09]
  2. FP6 project [LSHB CT 03 503480]

向作者/读者索取更多资源

The major pathway for HIV internalization in CD4+ T cells has been thought to be the direct fusion of virus and cell membranes, because the cell surface is the point of entry of infectious particles However, the exact contribution of endocytic pathways to the infection of CD4+ T lymphocytes is unknown, and the mechanisms involved in endocytosis of HIV particles are unclear Recent evidence suggests that endocytosis of cell-free and cell-associated virus particles could lead to effective virus entry and productive infections Such observations have, in turn, spurred a debate on the relevance of endosomal entry as a mechanism of escape from the immune system and HIV entry inhibitors In this paper, we review the endocytosis of HIV and discuss its role in HIV infection and pathogenesis

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report

Eudald Felip, Laia Llobera, Clara Perez-Mana, David Quintela, Ignacio Guasch, Mireia Margeli, Iris Teruel, Beatriz Cirauqui, Carmen Centeno, Margarita Romeo, Ester Ballana, Vanesa Quiroga

BREAST CARE (2020)

Article Oncology

Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy

Marc Castellvi, Eudald Felip, Ifeanyi Jude Ezeonwumelu, Roger Badia, Edurne Garcia-Vidal, Maria Pujantell, Lucia Gutierrez-Chamorro, Iris Teruel, Anna Martinez-Cardus, Bonaventura Clotet, Eva Riveira-Munoz, Mireia Margeli, Ester Ballana

CANCERS (2020)

Article Chemistry, Medicinal

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

Marianna Nalli, Jorge Armijos Rivera, Domiziana Masci, Antonio Coluccia, Roger Badia, Eva Riveira-Munoz, Alessandro Brambilla, Elisabetta Cinquina, Ombretta Turriziani, Francesca Falasca, Myriam Catalano, Cristina Limatola, Jose A. Este, Giovanni Maga, Romano Silvestri, Emmanuele Crespan, Giuseppe La Regina

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Immunology

Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial

Oriol Mitja, Marc Corbacho-Monne, Maria Ubals, Cristian Tebe, Judith Penafiel, Aurelio Tobias, Ester Ballana, Andrea Alemany, Nuria Riera-Marti, Carla A. Perez, Clara Suner, Pep Laporte, Pol Admella, Jordi Mitja, Mireia Clua, Laia Bertran, Maria Sarquella, Sergi Gavilan, Jordi Ara, Josep M. Argimon, Jordi Casabona, Gabriel Cuatrecasas, Paz Canadas, Aleix Elizalde-Torrent, Robert Fabregat, Magi Farre, Anna Forcada, Gemma Flores-Mateo, Esteve Muntada, Nuria Nadal, Silvia Narejos, Aroa Nieto, Nuria Prat, Jordi Puig, Carles Quinones, Juliana Reyes-Urena, Ferran Ramirez-Viaplana, Lidia Ruiz, Eva Riveira-Munoz, Alba Sierra, Cesar Velasco, Rosa Maria Vivanco-Hidalgo, Alexis Sentis, Camila G-Beiras, Bonaventura Clotet, Marti Vall-Mayans

Summary: A study conducted in Spain showed that early treatment with hydroxychloroquine did not bring more benefits than usual care for patients with mild COVID-19. The treatment did not reduce the risk of hospitalization or shorten the time to complete resolution of symptoms.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19

Oriol Mitja, Marc Corbacho-Monne, Maria Ubals, Andrea Alemany, Clara Suner, Cristian Tebe, Aurelio Tobias, Judith Penafiel, Ester Ballana, Carla A. Perez, Pol Admella, Nuria Riera-Marti, Pep Laporte, Jordi Mitja, Mireia Clua, Laia Bertran, Maria Sarquella, Sergi Gavilan, Jordi Ara, Josep M. Argimon, Gabriel Cuatrecasas, Paz Canadas, Aleix Elizalde-Torrent, Robert Fabregat, Magi Farre, Anna Forcada, Gemma Flores-Mateo, Cristina Lopez, Esteve Muntada, Nuria Nadal, Silvia Narejos, Aroa Nieto, Nuria Prat, Jordi Puig, Carles Quinones, Ferran Ramirez-Viaplana, Juliana Reyes-Uruena, Eva Riveira-Munoz, Lidia Ruiz, Sergi Sanz, Alexis Sentis, Alba Sierra, Cesar Velasco, Rosa M. Vivanco-Hidalgo, Juani Zamora, Jordi Casabona, Marti Vall-Mayans, Camila Gonzalez-Beiras, Bonaventura Clotet

Summary: In a trial involving asymptomatic contacts of patients with PCR-confirmed Covid-19 in Spain, the authors compared the use of hydroxychloroquine with usual care. Postexposure therapy with hydroxychloroquine did not prevent SARS-CoV-2 infection or symptomatic Covid-19 in healthy persons.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Infectious Diseases

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

Michael Marks, Pere Millat-Martinez, Dan Ouchi, Chrissy H. Roberts, Andrea Alemany, Marc Corbacho-Monne, Maria Ubals, Aurelio Tobias, Cristian Tebe, Ester Ballana, Quique Bassat, Barbara Baro, Marti Vall-Mayans, Camila G-Beiras, Nuria Prat, Jordi Ara, Bonaventura Clotet, Oriol Mitja

Summary: The viral load of index cases is a key driver of SARS-CoV-2 transmission, while the viral load of contacts at baseline is strongly associated with the risk of developing symptomatic COVID-19 and shortening the incubation period in a dose-dependent manner.

LANCET INFECTIOUS DISEASES (2021)

Review Biochemistry & Molecular Biology

Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics

Lucia Gutierrez-Chamorro, Eudald Felip, Ifeanyi Jude Ezeonwumelu, Mireia Margeli, Ester Ballana

Summary: CDKs play crucial roles in cell proliferation and viral infections, with specific CDK inhibitors showing potential for treating viral infections as a novel therapeutic strategy. The development and repurposing of CDK inhibitors may offer new options in combating both known and emerging viruses.

TRENDS IN MICROBIOLOGY (2021)

Article Virology

SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients

Lucia Gutierrez-Chamorro, Eva Riveira-Munoz, Clara Barrios, Vanesa Palau, Maria Nevot, Sonia Pedreno-Lopez, Jordi Senserrich, Marta Massanella, Bonaventura Clotet, Cecilia Cabrera, Oriol Mitja, Marta Crespo, Julio Pascual, Marta Riera, Ester Ballana

Summary: The study found that soluble functional ACE2 levels increase upon SARS-CoV-2 infection in swabs and plasma of infected patients, but rapidly decrease during the course of infection alongside ACE2 gene expression. Similarly, SARS-CoV-2 infection induced the expression of inflammatory cytokines, which correlated positively with viral load.

VIRUSES-BASEL (2021)

Letter Immunology

SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells

Daniel Perez-Zsolt, Jordana Munoz-Basagoiti, Jordi Rodon, Marc Elosua-Bayes, Dalia Raich-Regue, Cristina Risco, Martin Sachse, Maria Pino, Sanjeev Gumber, Mirko Paiardini, Jakub Chojnacki, Itziar Erkizia, Xabier Muniz-Trabudua, Ester Ballana, Eva Riveira-Munoz, Marc Noguera-Julian, Roger Paredes, Benjamin Trinite, Ferran Tarres-Freixas, Ignacio Blanco, Victor Guallar, Jorge Carrillo, Julia Blanco, Amalio Telenti, Holger Heyn, Joaquim Segales, Bonaventura Clotet, Javier Martinez-Picado, Julia Vergara-Alert, Nuria Izquierdo-Useros

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Virology

JAK-STAT Pathway: A Novel Target to Tackle Viral Infections

Ifeanyi Jude Ezeonwumelu, Edurne Garcia-Vidal, Ester Ballana

Summary: The modulation of the antiviral innate immune response through targeting the JAK-STAT pathway has been proposed for the development of novel pan-viral therapeutic strategies. Viruses have evolved diverse strategies to interfere with JAK-STAT signaling, highlighting its relevance as a potential antiviral target. Recent advances in JAK inhibitors have shown efficacy against various viral infections and may represent good candidates for drug repurposing strategies.

VIRUSES-BASEL (2021)

Article Biochemical Research Methods

Small form factor flow virometer for SARS-CoV-2

Rubaiya Hussain, Alfredo E. Ongaro, Maria L. Rodriguez de la Concepcion, Ewelina Wajs, Eva Riveira-Munoz, Ester Ballana, Julia Blanco, Ruth Toledo, Anna Chamorro, Marta Massanella, Lourdes Mateu, Eulalia Grau, Bonaventura Clotet, Jorge Carrillo, Valerio Pruneri

Summary: This study reports a novel optofluidic technology for rapid and reliable detection of SARS-CoV-2 in saliva samples. The technology exhibits high sensitivity and specificity, as well as short time-to-result and small size, making it suitable for point-of-care diagnostics and low resource settings.

BIOMEDICAL OPTICS EXPRESS (2022)

Article Oncology

Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types

Eudald Felip, Lucia Gutierrez-Chamorro, Maica Gomez, Edurne Garcia-Vidal, Margarita Romeo, Teresa Moran, Laura Layos, Laia Perez-Roca, Eva Riveira-Munoz, Bonaventura Clotet, Pedro Luis Fernandez, Ricard Mesia, Anna Martinez-Cardus, Ester Ballana, Mireia Margeli

Summary: The study found that tumors with low SAMHD1 expression have better prognosis in breast, ovarian, and lung cancer. Moreover, low SAMHD1 expression is a positive predictive factor in lung and ovarian cancer treated with certain drugs. In vitro experiments also showed that SAMHD1 depletion leads to DNA damage and cell apoptosis in tumor cells. These results suggest the clinical importance of SAMHD1 in personalized cancer treatments.

CANCERS (2022)

Article Microbiology

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice

Ferran Tarres-Freixas, Benjamin Trinite, Anna Pons-Grifols, Miguel Romero-Durana, Eva Riveira-Munoz, Carlos avila-Nieto, Monica Perez, Edurne Garcia-Vidal, Daniel Perez-Zsolt, Jordana Munoz-Basagoiti, Dalia Raich-Regue, Nuria Izquierdo-Useros, Cristina Andres, Andres Anton, Tomas Pumarola, Ignacio Blanco, Marc Noguera-Julian, Victor Guallar, Rosalba Lepore, Alfonso Valencia, Victor Urrea, Julia Vergara-Alert, Bonaventura Clotet, Ester Ballana, Jorge Carrillo, Joaquim Segales, Julia Blanco

Summary: The study found that the emerging SARS-CoV-2 variants show heterogeneous infectivity and pathogenesis in mice models, with B.1.351/Beta variant being the most pathogenic and BA.1.1/Omicron leading to lower viral RNA levels.

FRONTIERS IN MICROBIOLOGY (2022)

Article Microbiology

Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern

Dalia Raich-Regue, Jordana Munoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Edwards Pradenas, Eva Riveira-Munoz, Neus Gimenez, Assumpta Carabaza, Francesc Gimenez, Veronica Saludes, Elisa Martro, Neus Robert, Ignacio Blanco, Roger Paredes, Lidia Ruiz, Ester Ballana, Bonaventura Clotet, Julia Blanco, Nuria Izquierdo-Useros

Summary: The SARS-CoV-2 antigen-detecting rapid diagnostic test (Ag-RDTs) plays an important role in identifying new infections, but its sensitivity to different variants varies. Certain Ag-RDTs have shown a more than 10-fold reduction in detection capability for the Delta and Alpha variants, while the Beta and Omicron variants have not been affected. Therefore, continuous monitoring of Ag-RDTs performance is crucial for successful contact tracing.

FRONTIERS IN MICROBIOLOGY (2022)

Article Immunology

Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals

Edwards Pradenas, Maria Ubals, Victor Urrea, Clara Suner, Benjamin Trinite, Eva Riveira-Munoz, Silvia Marfil, Carlos Avila-Nieto, Maria Luisa Rodriguez de la Concepcion, Ferran Tarres-Freixas, Josep Laporte, Ester Ballana, Jorge Carrillo, Bonaventura Clotet, Oriol Mitja, Julia Blanco

Summary: This cohort study investigates the determinants of humoral responses and neutralizing titers in individuals with mild COVID-19. The results show that the duration of symptoms and age, rather than viral load, contribute to higher humoral responses. Individuals with high or low viral load exhibit similar neutralizing antibody titers at day 60, while non-early seroconverters have lower antibody titers but similar neutralizing activity.

FRONTIERS IN IMMUNOLOGY (2022)

暂无数据